Aristides Capital’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-52,849
Closed -$80.9K 261
2024
Q4
$80.9K Buy
+52,849
New +$80.9K 0.02% 274